ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.97349
0.01%
Brent Oil
82.835
-0.95%
Bitcoin
62,451.17
5.63%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. 2seventy bio Inc (TSVT)

  7. 2seventy bio Inc (TSVT) Noticias

TSVT 2seventy bio Inc

4.76
-0.17 (-3.45%)
Fuera de horario
Última actualización: 15:02:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
2seventy bio Inc TSVT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.17 -3.45% 4.76 15:02:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.93 4.60 5.1299 4.74 4.93
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202406:00BW2seventy bio to Report First Quarter 2024 Financial Results..
05/4/202408:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
01/4/202406:30BW2seventy bio Announces Completion of Oncology and Autoimmune..
20/3/202416:04BW2seventy bio Announces Appointments of Eli Casdin and..
15/3/202417:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
07/3/202415:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202406:03EDGAR2Form 8-K - Current report
05/3/202406:00BW2seventy bio Reports Fourth Quarter and Full Year 2023..
01/3/202406:00BW2seventy bio to Report Fourth Quarter and Full Year 2023..
05/2/202415:05BW2seventy bio to Participate in Upcoming Investor Conferences
05/2/202406:02EDGAR2Form 8-K - Current report
05/2/202405:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
02/2/202415:54EDGAR2Form 8-K/A - Current report: [Amend]
30/1/202408:25APSBiotech Shares Soar Premarket On Sale Of R&D Assets
30/1/202406:48EDGAR2Form 8-K - Current report
30/1/202406:01BW2seventy bio Announces New Strategic Path Forward
05/1/202415:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/12/202306:25EDGAR2Form 8-K - Current report
11/12/202318:30BWAbecma Delivers Sustained Progression-Free Survival Versus..
11/12/202306:00BW2seventy bio to Host Investor Call at 8:00am ET on Tuesday,..
06/12/202313:00BW2seventy bio Reiterates Commitment to Maximizing Shareholder..
01/12/202305:49EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/12/202305:46EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/12/202305:43EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01/12/202305:40EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
20/11/202313:31DJNTrending: Bristol Myers Squibb's Blood Cancer Treatment..
20/11/202307:30DJN2seventy Bio Shares Fall Premarket on Abecma Expansion Delay
20/11/202306:56DJNFDA Advisory Panel to Meet on Earlier Use of Abecma From..
20/11/202306:20EDGAR2Form 8-K - Current report
20/11/202305:59BWBristol Myers Squibb and 2seventy bio Provide Update on U.S...
14/11/202306:00BW2seventy bio Reports Third Quarter Financial Results and..
10/11/202306:00BW2seventy bio to Report Third Quarter 2023 Financial Results..
26/10/202306:05EDGAR2Form 8-K - Current report
13/9/202315:03EDGAR2Form 8-K - Current report
12/9/202306:13EDGAR2Form 8-K - Current report
12/9/202306:00BW2seventy bio Announces Strategic Restructuring to Prioritize..
12/9/202305:55BW2seventy bio and JW Therapeutics Announce Intent To Expand..
06/9/202315:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/9/202306:00BW2seventy bio to Participate in the 2023 Morgan Stanley..
16/8/202318:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202317:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202319:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202306:02EDGAR2Form 8-K - Current report
14/8/202306:00BW2seventy bio Reports Second Quarter Financial Results and..
08/8/202306:00BW2seventy bio to Report Second Quarter 2023 Financial Results..
01/8/202315:15BW2seventy bio to Participate in 2023 Wedbush PacGrow..
27/7/202308:16EDGAR2Form 8-K - Current report
14/6/202306:00BW2seventy bio Announces Clinical Study Pause of PLAT-08 Trial..
07/6/202306:00BW2seventy bio to Participate in Upcoming Investor Conference

Su Consulta Reciente

NASDAQ
TSVT
2seventy bio
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados